glp-1 and hypertension Agonists Blood Pressure: A Review of the Evidence | Current Reports GLP-1RA in Different HFpEF Phenotypes

Abstract Tirzepatide, a dual agonist for glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, has shown robust efficacy in treating diabetes and obesity, and in obese patients with heart failure with preserved ejection fraction (HFpEF), it reduced weight, lowered blood pressure, and improved outcomes

Its a one-two punch that promises to make us leaner, stronger and fitter than we ever dreamed possible

"Dairy products that support satiety, particularly those with protein and fiber, could play a key role helping consumers on this long-term weight management journey." When asked to narrow down what specific dairy product best meets the needs of GLP-1 users, Stone quickly points to Greek yogurt

Initial concerns regarding the possible link between the use of GLP-1 RAs and the development of pancreatitis or pancreatic cancer have not been supported by the results of RCTs [53,54], or real-world data [29,55,56]